Shridar Ganesan

11PUBLICATIONS
88CO-AUTHORS
Molecular targetsHaematological tumoursHaematologyTe mahi kaute o te Māori (Māori accounting)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 29, 2025
C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3.

Julia Yemelyanenko, Jinhyuk Bhin, Eline van der Burg

|Sep 15, 2025
Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical Outcomes.

Mona Arabzadeh, Yi-Han Tang, Christelle Colin-Leitzinger

|Jan 09, 2025
Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes.

Akshada Sawant, Fuqian Shi, Eduardo Cararo Lopes

|Dec 14, 2023
Treating Early and Often: Targeted Therapeutics in the Adjuvant Setting.

Shridar Ganesan

|Sep 22, 2023
Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study.

Jamila Mammadova, Christelle Colin-Leitzinger, Diep Nguyen

Pageof 2